D. Rowen

发表

Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.

Donna Rowen, Louise Longworth, L. Longworth, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The development of a QALY measure for epilepsy: NEWQOL-6D

G. Baker, A. Jacoby, J. Brazier, 2012, Epilepsy & Behavior.

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.

J. Brazier, A. Tsuchiya, L. Longworth, 2014, Health technology assessment.

A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale

J. Brazier, D. Rowen, B. van Hout, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values

J. Brazier, D. Rowen, S. Harnan, 2019, Applied Health Economics and Health Policy.

NICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values [Internet]

J. Brazier, D. Rowen, 2011 .

Developing a dementia-specific preference-based quality of life measure (AD-5D) in Australia: a valuation study protocol

T. Comans, J. Ratcliffe, D. Rowen, 2018, BMJ Open.

Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Benjamin M Craig, John Brazier, Donna Rowen, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Common Scale Valuations across Different Preference-Based Measures

J. Brazier, A. Tsuchiya, D. Rowen, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff

T. Comans, J. Ratcliffe, D. Rowen, 2020, PharmacoEconomics.

PROM Validation Using Paper-Based or Online Surveys: Data Collection Methods Affect the Sociodemographic and Health Profile of the Sample.

D. Rowen, J. Elliott, J. Carlton, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Estimating an exchange rate between the EQ-5D-3L and ASCOT

J. Brazier, K. Stevens, D. Rowen, 2017, The European Journal of Health Economics.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

J. Cairns, J. Brazier, A. Tsuchiya, 2014, Health technology assessment.

Ethical Principles and Economic Analysis

D. Rowen, M. Dietrich, 2005 .

Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI

Aki Tsuchiya, Brendan Mulhern, John Brazier, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Response to Comments on Mulhern et al., “Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis”

J. Brazier, Sube Banerjee, D. Rowen, 2012 .

NICE DSU TECHNICAL SUPPORT DOCUMENT 11 : ALTERNATIVES TO EQ-5 D FOR GENERATING HEALTH STATE UTILITY

J. Cairns, J. Brazier, D. Rowen, 2012 .

The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results

J. Brazier, A. Tsuchiya, D. Rowen, 2009 .

From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation

J. Ratcliffe, K. Stevens, D. Rowen, 2014, Health and Quality of Life Outcomes.

A Review of the Psychometric Performance of Selected Child and Adolescent Preference-Based Measures Used to Produce Utilities for Child and Adolescent Health.

A. Wailoo, A. Keetharuth, D. Rowen, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?

J. Brazier, D. Rowen, A. Lloyd, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Experience-based utility and own health state valuation: why do it and how to do it

J. Brazier, A. Tsuchiya, J. Ratcliffe, 2017 .

Discrete choice experiments or best-worst scaling? A qualitative study to determine the suitability of preference elicitation tasks in research with children and young people

D. Rowen, Z. Marshman, H. Rodd, 2021, Journal of Patient-Reported Outcomes.

Androgen Deprivation Therapy for Prostate Cancer Prevention: What Impact Do Related Adverse Events Have on Quality of Life?

J. Brazier, C. Kerr, D. Rowen, 2012 .

Exploring the Issues of Valuing Child and Adolescent Health States Using a Mixed Sample of Adolescents and Adults

A. Wailoo, D. Rowen, C. Mukuria, 2022, PharmacoEconomics.

Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care

S. Paisley, J. Brazier, D. Rowen, 2017, PharmacoEconomics.

Developing a questionnaire to determine evaluation of self-management in diabetes:

J. Brazier, K. Meadows, K. Stevens, 2017 .

Examining productivity losses associated with health related quality of life using patient data

S. Dixon, D. Rowen, C. Mukuria, 2013 .

What Matters for Evaluating the Quality of Mental Healthcare? Identifying Important Aspects in Qualitative Focus Groups with Service Users and Frontline Mental Health Professionals

D. Rowen, P. Powell, 2022, The Patient - Patient-Centered Outcomes Research.

Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR

C. Wojek, A. Charil, J. Brazier, 2020, Trials.

HEDS Discussion Paper 11/07

M. Barkham, J. Brazier, D. Rowen, 2014 .

This is a repository copy of Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based

J. Whitty, J. Cleland, D. Rowen, 2019 .

Multiattribute Utility Instruments: Condition-Specific Versions

J. Brazier, D. Rowen, 2014 .

Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?

O. Rivero-Arias, D. Rowen, K. Shah, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review

A. Wailoo, A. Keetharuth, D. Rowen, 2022, Health and Quality of Life Outcomes.

A Discrete Choice Experiment to Elicit General Population Preferences Around the Factors Influencing the Choice to Make Clinical Negligence Claims.

A. Wailoo, A. Keetharuth, D. Rowen, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report

A. Charil, J. Brazier, T. Peto, 2022, Scientific Reports.

Convergent validity of EQ-5D with core outcomes in dementia: a systematic review

A. Wailoo, A. Keetharuth, D. Rowen, 2022, Health and Quality of Life Outcomes.

What Matters for Evaluating the Quality of Mental Healthcare? Identifying Important Aspects in Qualitative Focus Groups with Service Users and Frontline Mental Health Professionals

D. Rowen, P. Powell, 2022, The Patient - Patient-Centered Outcomes Research.

Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report

G. Rubin, A. Charil, J. Brazier, 2022, Scientific Reports.

Characteristics and Spatial Distribution of Structural Features in Age-related Macular Degeneration-a MACUSTAR Study Report.

G. Rubin, A. Charil, T. Peto, 2022, Ophthalmology. Retina.

International Regulations and Recommendations for Utility Data for Health Technology Assessment

D. Rowen, B. Hout, I. Azzabi Zouraq, 2017, PharmacoEconomics.

Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.

Kia-Chong Chua, D. Lamping, J. Brazier, 2013, Health technology assessment.

Mapping Functions in Health-Related Quality of Life

Donna Rowen, Tracey A. Young, Clara Mukuria, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Valuing quality in mental healthcare: A discrete choice experiment eliciting preferences from mental healthcare service users, mental healthcare professionals and the general population.

D. Rowen, R. Jacobs, A. Hole, 2022, Social science & medicine.

U.K. utility weights for the EORTC QLU-C10D.

D. Street, D. Cella, D. Revicki, 2019, Health economics.

Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol

J. Brazier, D. Rowen, P. Powell, 2019, BMJ Open.

Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30

P. Fayers, D. Street, D. Cella, 2017, PharmacoEconomics.

Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format

M. T. King, N. K. Aaronson, J. E. Brazier, 2016, Quality of Life Research.

Adolescent valuation of CARIES-QC-U: a child-centred preference-based measure of dental caries

D. Rowen, Z. Marshman, H. Rodd, 2022, Health and Quality of Life Outcomes.

Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life

S. Whyte, P. Shackley, J. Brazier, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale

J. Brazier, A. Tsuchiya, D. Rowen, 2012, The European Journal of Health Economics.

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures

Aki Tsuchiya, Yaling Yang, John E. Brazier, 2010, The European Journal of Health Economics.

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?

John Brazier, Donna Rowen, Jennifer Roberts, 2009, Health and quality of life outcomes.

Estimating a Dutch Value Set for the Pediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration.

Brendan Mulhern, Donna Rowen, Katherine Stevens, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL.

J. Brazier, R. Norman, D. Rowen, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods

J. Brazier, D. Rowen, M. Guglieri, 2021, Neurology.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30

P. Fayers, D. Cella, N. Aaronson, 2016, Quality of Life Research.

Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.

L. Matza, J. Brazier, D. Rowen, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Health Utility Measurement

J. Brazier, D. Rowen, 2011 .

Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?

Donna Rowen, Julie Ratcliffe, Oliver Rivero-Arias, 2020, PharmacoEconomics.

Do Portuguese and UK health state values differ across valuation methods?

J. Brazier, P. Ferreira, D. Rowen, 2011, Quality of Life Research.

Using rank and discrete choice data to estimate health state utility values on the QALY scale

J. Brazier, A. Tsuchiya, D. Rowen, 2009 .

A conceptual comparison of well-being measures used in the UK

J. Brazier, D. Rowen, T. Peasgood, 2014 .

Development of the CFQ-R-8D: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised.

S. Acaster, J. Brazier, A. Quittner, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma

Donna Rowen, Anna Morley, N. Maskell, 2015, Health and Quality of Life Outcomes.

Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).

M. Barkham, J. Brazier, A. Tsuchiya, 2012, Health technology assessment.

Developing an Australian utility value set for MacNew-7D health states

Gang Chen, D. Rowen, B. Mulhern, 2022, Quality of Life Research.

Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument

P. Scuffham, J. Whitty, S. McPhail, 2021, Quality of Life Research.

Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report

J. Brazier, D. Rowen, U. Luhmann, 2022, British Journal of Ophthalmology.

Assessment of the psychometric properties and refinement of the Health and Self-Management in Diabetes Questionnaire (HASMID)

D. Rowen, J. Elliott, J. Carlton, 2020, Health and Quality of Life Outcomes.

The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment

John Brazier, Donna Rowen, Roberta Ara, 2017, PharmacoEconomics.

Developing preference‐based measures for diabetes: DHP‐3D and DHP‐5D

J. Brazier, K. Meadows, D. Rowen, 2017, Diabetic medicine : a journal of the British Diabetic Association.

An empirical comparison of well-being measures used in the UK

J. Brazier, D. Rowen, T. Peasgood, 2016 .

Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.

J. Brazier, D. Rowen, T. Young, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Estimating a Preference-Based Index from the Clinical Outcomes in Routine Evaluation–Outcome Measure (CORE-OM)

M. Barkham, J. Brazier, D. Rowen, 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

Developing preference-based health measures: using Rasch analysis to generate health state values

J. Brazier, D. Rowen, T. Young, 2010, Quality of Life Research.

Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D.

J. Brazier, D. Hughes, D. Rowen, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Comparison of General Population, Patient, and Carer Utility Values for Dementia Health States

J. Brazier, Sube Banerjee, D. Rowen, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

P. Fayers, N. Aaronson, M. King, 2022 .

Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy.

D. Lamping, J. Brazier, Sube Banerjee, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public

J. Brazier, A. Tsuchiya, O. Rivero-Arias, 2021, Health and Quality of Life Outcomes.

The EQ Health and Wellbeing: Overview of the Development of a Measure of Health and Wellbeing and Key Results.

J. Connell, J. Brazier, A. Tsuchiya, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Valuing states from multiple measures on the same visual analogue sale: a feasibility study.

Aki Tsuchiya, John Brazier, Donna Rowen, 2012, Health economics.

An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D

J. Brazier, A. Tsuchiya, L. Longworth, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L

J. Brazier, P. Lorgelly, D. Rowen, 2016, Quality of Life Research.

Estimating a Preference-Based Single Index Measuring the Quality-of-Life Impact of Self-Management for Diabetes

J. Brazier, K. Stevens, D. Rowen, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models

J. Brazier, D. Rowen, R. Ara, 2017, PharmacoEconomics.

Exploring the consistency of the SF-6D.

J. Brazier, P. Ferreira, D. Rowen, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Experience-based utility and own health state valuation for a health state classification system: why and how to do it

J. Brazier, A. Tsuchiya, J. Ratcliffe, 2017, The European Journal of Health Economics.

Developing a health, social care and carer-related quality of life instrument to measure QALYs

J. Connell, J. Brazier, N. Devlin, 2018 .

A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets

D. Rowen, C. Mukuria, E. McDool, 2022, PharmacoEconomics.

Improving the measurement of QALYs in dementia: developing patient- and carer-reported health state classification systems using Rasch analysis.

D. Lamping, J. Brazier, Sube Banerjee, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Preference-Based Assessments Exploring the Consistency of the SF6 D

J. Brazier, P. Ferreira, D. Rowen, 2013 .

Incorporating Ethics into Economics: Problems and Possibilities

D. Rowen, M. Dietrich, 2004 .

What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?

J. C. Rejon-Parrilla, J. Connell, J. Brazier, 2021, The European Journal of Health Economics.

Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index

J. Bjorner, J. Brazier, A. Keetharuth, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes.

J. Brazier, J. Ratcliffe, K. Stevens, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Use of Mapping to Estimate Health State Utility Values

Donna Rowen, Clara Mukuria, Roberta Ara, 2017, PharmacoEconomics.

Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice

J. Brazier, K. Meadows, K. Stevens, 2017, Health and Quality of Life Outcomes.

Mapping onto Eq-5 D for patients in poor health

Donna Rowen, Elly A Stolk, J. Brazier, 2010, Health and quality of life outcomes.

Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death

D. Rowen, A. Hatswell, B. Pennington, 2014, Health and Quality of Life Outcomes.

Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off technique.

N. Bray, L. Longworth, D. Rowen, 2022, Social science & medicine.

Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends

J. Brazier, D. Rowen, Haode Wang, 2023, Applied Health Economics and Health Policy.

Randomised comparison of online interviews versus face-to-face interviews to value health states

D. Rowen, T. Peasgood, K. Dalziel, 2023, Social science & medicine.

It’s All in the Name, or Is It? The Impact of Labeling on Health State Values

J. Brazier, A. Tsuchiya, D. Rowen, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

Estimating the SF-6D value set for a population-based sample of Brazilians.

Donna Rowen, J. Brazier, C. Polanczyk, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Transforming challenges into opportunities: conducting health preference research during the COVID-19 pandemic and beyond

R. Skolasky, D. Rowen, J. O’Dwyer, 2021, Quality of Life Research.

Selection and validation of a classification system for a child-centred preference-based measure of oral health-related quality of life specific to dental caries

D. Rowen, Z. Marshman, H. Rodd, 2020, Journal of Patient-Reported Outcomes.

Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population

G. Baker, A. Jacoby, J. Brazier, 2014, Epilepsy & Behavior.

The impact of adding an extra dimension to a preference-based measure

J. Brazier, A. Tsuchiya, D. Rowen, 2011, Social science & medicine.

Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.

D. Rowen, C. Lam, C. Wong, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Mapping the Functional Assessment of Cancer Therapy-general or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm.

S. McGhee, D. Rowen, D. Kwong, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report

A. Jacoby, J. Brazier, D. Hughes, 2010 .

Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.

John Brazier, Donna Rowen, Tracey Young, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2

Jakob B. Bjorner, John E. Ware, John E. Brazier, 2020, Medical care.

Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences

J. Brazier, N. Devlin, D. Rowen, 2022, Quality of Life Research.

A Review of the Methods Used to Generate Utility Values in NICE Technology Assessments for Children and Adolescents.

A. Wailoo, D. Rowen, R. Wong, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Examining the Feasibility and Acceptability of Valuing the Arabic Version of SF-6D in a Lebanese Population

J. Brazier, D. Rowen, D. Dawoud, 2020, International journal of environmental research and public health.

Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data

S. Dixon, D. Rowen, C. Mukuria, 2017, Applied Health Economics and Health Policy.

Reducing the Floor Effect in the SF-6D: A Feasibility Study

P. Ferreira, D. Rowen, L. Ferreira, 2012 .

A Portuguese value set for the SF-6D.

John Brazier, Donna Rowen, J. Brazier, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

1105PVEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION.

Y. S. Kim, Su Jin Lee, J. Utikal, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Should We Consider Including a Value for "Hope" as an Additional Benefit Within Health Technology Assessment?

A. Tsuchiya, A. Wailoo, D. Rowen, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Estimating informal care inputs associated with EQ-5D for use in economic evaluation

S. Dixon, D. Rowen, C. Mukuria, 2016, The European Journal of Health Economics.

Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study

C. Wojek, A. Charil, J. Brazier, 2021, BMC Medical Research Methodology.

Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness

J. Brazier, A. Tsuchiya, A. Keetharuth, 2015, Applied Health Economics and Health Policy.

Deriving a preference-based utility measure for cancer patients from the european Organisation for the Research and Treatment of cancer ’ s Quality of life Questionnaire c 30 : a confirmatory versus exploratory approach

P. Fayers, N. Aaronson, R. Viney, 2014 .

PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30

P. Fayers, D. Cella, N. Aaronson, 2012 .

Title: Update: Eliciting societal preferences for weighting QALYs according to burden of illness, size of gain and end of life

S. Whyte, P. Shackley, J. Brazier, 2014 .

PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped Utilities

D. Rowen, K. Tolley, Q. Wang, 2011 .

CA4 A Comparison of Patient and General-Population Utility Values for Advanced Melanoma in Health Economic Modelling

D. Rowen, B. Winn, M. Lebmeier, 2012 .

Two important points

A. Tsuchiya, D. Rowen, J. Brazier, 2010, BMJ : British Medical Journal.

Estimating a Preference-Based Single Index Measuring the Quality-of-Life Impact of Self-Management for Diabetes

J. Brazier, K. Stevens, D. Rowen, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures

J. Brazier, A. Tsuchiya, D. Rowen, 2010, The European Journal of Health Economics.

Estimating a Dutch value set for the paediatric preference-based CHU-9D using a discrete choice experiment with duration

D. Rowen, Brendan Mulhern, Katherine Stevens, 2019 .

Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: a mixed-methods study protocol

J. Brazier, D. Rowen, P. Powell, 2019, BMJ Open.

Preparatory study for the revaluation of the EQ-5D tariff: methodology report.

J. Cairns, J. Brazier, A. Tsuchiya, 2014, Health technology assessment.

Estimating the SF-6D value set for a population-based sample of Brazilians.

J. Brazier, C. Polanczyk, D. Rowen, 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses

J. Whitty, J. Cleland, D. Rowen, 2019, Heart Failure Reviews.

Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life

S. Whyte, P. Shackley, J. Brazier, 2016, Medical decision making : an international journal of the Society for Medical Decision Making.

Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?

M. Sculpher, M. Jit, R. Norman, 2023, PharmacoEconomics.

Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.

Kia-Chong Chua, D. Lamping, J. Brazier, 2013, Health technology assessment.

Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research

A. Coulter, T. Wykes, R. Fitzpatrick, 2016, Health and Quality of Life Outcomes.

Producing a preference‐based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed‐methods research protocol

F. Pouwer, J. Brazier, D. Rowen, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Valuing states from multiple measures on the same visual analogue sale: a feasibility study.

J. Brazier, A. Tsuchiya, D. Rowen, 2012, Health economics.

P. Fayers, N. Aaronson, M. King, 2022 .

Understanding UK public views on normative decisions made to value health-related quality of life in children: A qualitative study.

A. Keetharuth, D. Rowen, C. Mukuria, 2023, Social science & medicine.

The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment

J. Brazier, D. Rowen, R. Ara, 2017, PharmacoEconomics.